Document is current
Any future updates will be listed below
-
Authors
Cesaro, Angela
Hoffman, Samuel C.
Das, Payel
de la Fuente-Nunez, Cesar https://orcid.org/0000-0002-2005-5629
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 26 November 2024
First Online: 7 January 2025
Competing interests
: Cesar de la Fuente-Nunez provides consulting services to Invaio Sciences and is a member of the Scientific Advisory Boards of Nowture S.L., Peptidus, and Phare Bio. De la Fuente is also on the Advisory Board of the Peptide Drug Hunting Consortium (PDHC). The de la Fuente Lab has received research funding or in-kind donations from United Therapeutics, Strata Manufacturing PJSC, and Procter & Gamble, none of which were used in support of this work. All other authors declare no competing interests.
